Karl Collins

USPTO Granted Patents = 4 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 12.5

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

4 out of 12,160

Bayer Aktiengesellschaft

patents

4 out of 378

Bayer Pharma Aktiengesellschaft

patents

where one patent can have more than one assignee

Years Active: 2021-2024

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12180227 - Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders (2024-12-31),

2. 11208422 - Substituted bridged diazepane derivatives and use thereof as TASK-1 and TASK-3 inhibitors (2021-12-28),

3. 11208400 - Substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereof (2021-12-28),

4. 11098063 - Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders (2021-08-24),

Title: Karl Collins: Innovator from Düsseldorf

Introduction: Karl Collins is a renowned inventor hailing from Düsseldorf, Germany, known for his groundbreaking contributions to various fields.

Latest Patents: Karl Collins holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced manufacturing processes.

Career Highlights: With a career spanning over two decades, Karl Collins has worked with leading research institutions and multinational companies to develop cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Karl Collins has collaborated with top universities and innovative startups to bring his ideas to life, fostering a culture of creativity and progress.

Conclusion: Karl Collins continues to inspire the next generation of inventors with his passion for innovation and his dedication to creating a better future through his pioneering work.

This text is generated by artificial intelligence and may not be accurate.